Optisulin 100 IU/mL Solution for injection.
PDF Leaflet Revision Date: 31 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of diabetes mellitus in patients aged 2 years and older.
Dosage (summary)
Subcutaneous injection once daily, individualized dosing.
Special Populations
- Elderly
- Children < 2 years
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Can be used during pregnancy; insulin requirements may change. Adjustments may be needed during breastfeeding.
Key Drug Interactions
- Oral antidiabetic agents
- Corticosteroids
- Beta-blockers
Contraindications
- Hypersensitivity to insulin glargine
- Children < 2 years
Common side effects
- Hypoglycaemia
- Lipohypertrophy
- Injection site reactions
Counselling Points
- Rotate injection sites
- Monitor blood glucose regularly
- Be aware of hypoglycaemia symptoms
Serious warnings
- Risk of severe hypoglycaemia
- Not for diabetic ketoacidosis
Important Disclaimer
The Optisulin 100 IU/mL Solution for injection. professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
